Factorial Partners LLC Decreases Holdings in ZimVie Inc. (NASDAQ:ZIMV)

Factorial Partners LLC trimmed its holdings in ZimVie Inc. (NASDAQ:ZIMV) by 47.9% in the second quarter, according to the company in its most recent filing with the SEC. The fund owned 44,000 shares of the company’s stock after selling 40,400 shares during the quarter. Factorial Partners LLC’s holdings in ZimVie were worth $803,000 at the end of the most recent quarter.

Other institutional investors also recently made changes to their positions in the company. Cetera Advisors LLC bought a new position in ZimVie during the 1st quarter worth approximately $2,615,000. CenterBook Partners LP bought a new position in shares of ZimVie in the fourth quarter worth approximately $988,000. Gabelli Funds LLC increased its stake in shares of ZimVie by 25.4% in the fourth quarter. Gabelli Funds LLC now owns 40,260 shares of the company’s stock worth $715,000 after buying an additional 8,160 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in ZimVie by 6.3% during the 1st quarter. Price T Rowe Associates Inc. MD now owns 21,531 shares of the company’s stock valued at $356,000 after buying an additional 1,275 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its position in ZimVie by 21.1% during the 4th quarter. Charles Schwab Investment Management Inc. now owns 761,285 shares of the company’s stock valued at $13,513,000 after buying an additional 132,804 shares during the period. Hedge funds and other institutional investors own 95.63% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Needham & Company LLC boosted their price objective on shares of ZimVie from $20.00 to $23.00 and gave the company a “buy” rating in a research report on Friday, August 2nd.

Insider Transactions at ZimVie

In related news, major shareholder Camber Capital Management Lp sold 525,000 shares of the business’s stock in a transaction dated Friday, August 2nd. The shares were sold at an average price of $17.71, for a total transaction of $9,297,750.00. Following the transaction, the insider now owns 2,725,000 shares in the company, valued at $48,259,750. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Corporate insiders own 3.01% of the company’s stock.

ZimVie Price Performance

Shares of ZIMV stock opened at $16.72 on Wednesday. The company has a debt-to-equity ratio of 0.62, a quick ratio of 1.43 and a current ratio of 1.94. ZimVie Inc. has a fifty-two week low of $6.52 and a fifty-two week high of $22.40. The firm has a market cap of $456.27 million, a P/E ratio of -1.20 and a beta of 2.14. The business’s 50 day moving average price is $18.43 and its 200-day moving average price is $17.25.

ZimVie (NASDAQ:ZIMV) last announced its quarterly earnings results on Thursday, August 1st. The company reported $0.13 EPS for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.04). The business had revenue of $116.81 million during the quarter. ZimVie had a positive return on equity of 2.21% and a negative net margin of 63.84%. During the same period last year, the firm earned $0.17 earnings per share. On average, equities research analysts anticipate that ZimVie Inc. will post 0.63 earnings per share for the current year.

ZimVie Company Profile

ZimVie Inc, together with its subsidiaries, develops, manufactures, and markets a portfolio of products and solutions designed to treat various spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It operates through two segments, The Dental Segment and The Spine Segment.